Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV
· Real-Time Price · USD
12.39
0.46 (3.86%)
At close: Sep 02, 2025, 3:59 PM
3.86% (1D)
| Bid | 12.34 |
| Market Cap | 8.46B |
| Revenue (ttm) | 23.23M |
| Net Income (ttm) | -490.63M |
| EPS (ttm) | -1.09 |
| PE Ratio (ttm) | -11.37 |
| Forward PE | -9.7 |
| Analyst | Buy |
| Ask | 12.42 |
| Volume | 8,776,219 |
| Avg. Volume (20D) | 5,662,861 |
| Open | 11.95 |
| Previous Close | 11.93 |
| Day's Range | 11.94 - 12.46 |
| 52-Week Range | 8.73 - 13.05 |
| Beta | 1.15 |
About ROIV
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ROIV
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ROIV stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Roivant Sciences Ltd. is scheduled to release its earnings on
Nov 11, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
+6.4%
Roivant Sciences shares are trading higher followi...
Unlock content with
Pro Subscription
2 weeks ago · seekingalpha.com
Roivant Sciences: Vant Model And IMVT-1402 Create A 2025 Catalyst StackRoivant Sciences Ltd.'s Vant model gives it risk-isolated development, monetization flexibility, and diversified optionality. ROIV's main value drivers are Immunovant, Priovant, Pulmovant, and Genevan...
